购物车
- 全部删除
- 您的购物车当前为空
Remibrutinib 是有效的、口服具有活力的 bruton tyrosine kinase 抑制剂 (IC50:1 nM),在血液中抑制 BTK 活性的 IC50的值为 0.23 μM。它具有研究慢性荨麻疹的潜力。
为众多的药物研发团队赋能,
让新药发现更简单!
Remibrutinib 是有效的、口服具有活力的 bruton tyrosine kinase 抑制剂 (IC50:1 nM),在血液中抑制 BTK 活性的 IC50的值为 0.23 μM。它具有研究慢性荨麻疹的潜力。
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
1 mg | ¥ 893 | 现货 | |
5 mg | ¥ 2,160 | 现货 | |
10 mg | ¥ 3,490 | 现货 | |
25 mg | ¥ 5,690 | 现货 | |
50 mg | ¥ 7,960 | 现货 | |
100 mg | ¥ 10,700 | 现货 | |
1 mL x 10 mM (in DMSO) | ¥ 2,390 | 现货 |
产品描述 | Remibrutinib inhibits BTK activity with an IC50 value of 0.023 μM in blood. Remibrutinib is an effective and orally active Bruton tyrosine kinase inhibitor (IC50: 1 nM). Remibrutinib has the potential for Chronic urticaria (CU) treatment. |
靶点活性 | BTK:1 nM |
体外活性 | Remibrutinib inhibits Btk enzymatic activity (IC50: 1 nM in a biochemical enzyme assay). Remibrutinib inhibits Btk enzymatic activity in the blood (IC50: 0.023 μM in vitro B cell activation assay), the whole blood is collected from the abdominal aorta of anesthetized adult male Lewis rats[1]. |
分子量 | 507.53 |
分子式 | C27H27F2N5O3 |
CAS No. | 1787294-07-8 |
存储 | store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | |||||||||||||||||||||||||||||||||||
溶解度信息 | DMSO: 125 mg/mL (246.29 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
溶液配制表 | ||||||||||||||||||||||||||||||||||||
DMSO
|
版权所有©2015-2024 TargetMol Chemicals Inc.保留所有权利.